Advanced Search

Extraction Form Preview:

Comparative studies


Arm Name Suggestions

No arms specified.

Arm Details










... Define:
... Define:
... Define:
... Define:
... Define:
... Define:
... Define:
... Define:
... Define:
... Define:
... Define:
Row Headers
Surgery
Margin width (mm)
TCA (explicitly mentioned)
Row Headers
Surgery
Surgery type
Description (if other)
Row Headers
Intervention 1
Intervention
Description
Number of passes
Type of electric current (laser)
Curettage
Row Headers
Protocol 1
Type/particle
Dosage (cumulative)
Fractionation scheme (no. sessions)
Frequency
Duration
Route
Row Headers
Protocol
Light source/wavelength
Surface preparation
Fractionation scheme (no. sessions)
Frequency
Duration
Light dose
Light intensity
Time between treatments
Photosensitizer molecule
Photosensitizer concentration
Total light dose
Row Headers
Drug
Name/molecule
Route
Frequency
Duration
Concentration
Special instruction
Row Headers
Surgery 1
Margin (mm)
Row Headers
Surgery
Number of passes/proceedures

Design Details and Enrollment














... Describe
... Describe
... Describe
...
...
...
...
Row Headers
number
N enrolled
N randomized (if applicable)
N analyzed

Baseline Characteristics Fields

Row Headers
N Patients
N lesions
Reasons given
Enrolled
Randomized
Drop out
Analyzed
Row Headers
Mean
SD
SE
Median
IQR
Full range
Notes/description
Age
Lesion diameter
Lesion area
Number of lesions
Row Headers
n
%
Notes
1
2
>=3
Row Headers
n
%
Notes/description
Female
Race: Black or African American
Race: White
Race: Other
Row Headers
n
%
Notes
Hands
Face
Scalp
Lip
Eyelid
Ear
Extremities
Trunk/neck
Genitalia
Row Headers
n
%
I
II
III
IV
V
Row Headers
n
%
Treatment type
Tx 1
Tx 2
Tx 3
Tx 4
Tx 5
Row Headers
n
%
Notes
Post-transplant
HIV+
CLL (Chronic Lymphocytic Leukemia)
Solid cancers/leukemia
Immunologic diseases (RA, Lupus, etc.)
Total (unspecified)
Row Headers
BCC
Notes/Description
Total
In situ
Superficial/multicentric
Nodular
High risk: Infiltrative/micronodular/morphea form/scelorosing
Basosqamous
Row Headers
SCC
Notes/Description
Total
Bowen's/in situ
Well differntiated
Moderately differntiated
Poorly differntiated

Outcome Name Suggestions

Outcome Title Note
Cosmetic outcome (categorical) Describe how ascertained (patient-reported vs. third person); scale used (if given); cut offs
Cosmetic outcome (continuous) Describe how ascertained (patient-reported vs. third person); scale used (if given)
Quality of life (generic) Scale used; cutoffs
Quality of life (generic) Scale used
Quality of life (skin specific) Scale used; cutoffs
Quality of life (skin specific) Scale used
Mental health, anxiety, depression, intrusive thoughts Scale used; cutoffs
Mental health, anxiety, depression, intrusive thoughts Scale used
Patient satisfaction with treatment Scale used (e.g. Patient Satisfaction Questionnaire-18); cutoffs
Patient satisfaction with treatment Scale used (Patient Satisfaction Questionnaire-18)
Long-term Mortality >= 1 year (discuss followup time with Marty and Aaron)
Resource utilization Procedure charges/costs
Adverse events: skin irritation
Number of repeat procedures
Adverse events: pain
Adverse events: scarring
Adverse events: discomfort
Adverse events: other
Recurrence or relapse
Incomplete excision
Lack of clinical clearance (1-clinical clearance)
Lack of histological clearance (1-histological clearance)
Adverse events: Any
Adverse events: Any leading to discontinuation
Adverse events: Any serious/severe
Adverse event: infection


Quality Dimension Fields

Quality Dimension Value Notes
RCT:....Adequate generation of a randomized sequence reported
RCT:....Adequate allocation concealment reported
RCT:....Adequate blinding of PATIENTS reported
RCT:....Adequate blinding of PROVIDERS reported
ALL....Adequate blinding of OUTCOME ASSESSORS reported
ALL.....Incomplete results data: are more than 20% missing for any eligible outcome in any group?
ALL.....Selective Reporting (judgement - put directly into notes field).
RCT.....Is the treatment effect by Intention to treat?
ALL....Group similarity at baseline.
ALL....Additional Bias: Bias due to problems not covered elsewhere. (judgement - put directly into notes field)
ALL (with AE results)....Were reported adverse events (of interest) precisely defined
Overall, by outcome (judgement - put directly into notes field)
ALL.....Incomplete results data: Is there differential missingness (more than 20%) between arms for any eligible outcome?

Overall Rating of Study:
Quality Guideline Used in Assessment: